These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 10954033)

  • 1. The role of tachykinins via NK1 receptors in progression of human gliomas.
    Palma C; Maggi CA
    Life Sci; 2000; 67(9):985-1001. PubMed ID: 10954033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Substance P and its receptors -- a potential target for novel medicines in malignant brain tumour therapies (mini-review).
    Łazarczyk M; Matyja E; Lipkowski A
    Folia Neuropathol; 2007; 45(3):99-107. PubMed ID: 17849359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-tumour activity of tachykinin NK1 receptor antagonists on human glioma U373 MG xenograft.
    Palma C; Bigioni M; Irrissuto C; Nardelli F; Maggi CA; Manzini S
    Br J Cancer; 2000 Jan; 82(2):480-7. PubMed ID: 10646908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Receptors mediating tachykinin-evoked depolarisations of neurons in the neonatal rat spinal cord.
    Fox AJ; Naeem S; Patel IA; Walpole C; Urbán L
    Acta Biol Hung; 1996; 47(1-4):129-44. PubMed ID: 9123986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Substance P activates responses correlated with tumour growth in human glioma cell lines bearing tachykinin NK1 receptors.
    Palma C; Nardelli F; Manzini S; Maggi CA
    Br J Cancer; 1999 Jan; 79(2):236-43. PubMed ID: 9888463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating the role of substance P in the growth of brain tumors.
    Harford-Wright E; Lewis KM; Vink R; Ghabriel MN
    Neuroscience; 2014 Mar; 261():85-94. PubMed ID: 24374326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular and behavioural effects of centrally administered tachykinins in the rat: characterization of receptors with selective antagonists.
    Picard P; Regoli D; Couture R
    Br J Pharmacol; 1994 May; 112(1):240-9. PubMed ID: 7518304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence that tachykinins relax the guinea-pig trachea via nitric oxide release and by stimulation of a septide-insensitive NK1 receptor.
    Figini M; Emanueli C; Bertrand C; Javdan P; Geppetti P
    Br J Pharmacol; 1996 Mar; 117(6):1270-6. PubMed ID: 8882625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electrophysiological characterisation of tachykinin receptors in the rat nucleus of the solitary tract and dorsal motor nucleus of the vagus in vitro.
    Maubach KA; Jones RS
    Br J Pharmacol; 1997 Nov; 122(6):1151-9. PubMed ID: 9401780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurokinin receptors (NK1, NK2) in the mouse: a pharmacological study.
    Nsa Allogho S; Nguyen-Le XK; Gobeil F; Pheng LH; Regoli D
    Can J Physiol Pharmacol; 1997 Jun; 75(6):552-7. PubMed ID: 9276127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemokinin-1 and substance P stimulate production of inflammatory cytokines and chemokines in human colonic mucosa via both NK
    Dai L; Perera DS; Burcher E; Liu L
    Neuropeptides; 2020 Aug; 82():102061. PubMed ID: 32600668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of tachykinin NK1 and NK2 receptors in the circular muscle of the guinea-pig ileum and proximal colon.
    Maggi CA; Patacchini R; Meini S; Quartara L; Sisto A; Potier E; Giuliani S; Giachetti A
    Br J Pharmacol; 1994 May; 112(1):150-60. PubMed ID: 7518302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The tachykinin NK1 receptor in the brain: pharmacology and putative functions.
    Saria A
    Eur J Pharmacol; 1999 Jun; 375(1-3):51-60. PubMed ID: 10443564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The new neurokinin 1-sensitive receptor mediates the facilitation by endogenous tachykinins of the NMDA-evoked release of acetylcholine after suppression of dopaminergic transmission in the matrix of the rat striatum.
    Kemel ML; Pérez S; Beaujouan JC; Jabourian M; Soubrié P; Glowinski J
    J Neurochem; 2003 Oct; 87(2):487-96. PubMed ID: 14511126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation between binding characteristics and functional antagonism in human glioma cells by tachykinin NK1 receptor antagonists.
    Palma C; Nardelli F; Manzini S
    Eur J Pharmacol; 1999 Jun; 374(3):435-43. PubMed ID: 10422788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of two novel tachykinin antagonists, FK224 and FK888, on neurogenic airway plasma exudation, bronchoconstriction and systemic hypotension in guinea-pigs in vivo.
    Hirayama Y; Lei YH; Barnes PJ; Rogers DF
    Br J Pharmacol; 1993 Mar; 108(3):844-51. PubMed ID: 7682142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of substance P in the cardiovascular system.
    Mistrova E; Kruzliak P; Chottova Dvorakova M
    Neuropeptides; 2016 Aug; 58():41-51. PubMed ID: 26706184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in the distribution and characteristics of tachykinin NK1 binding sites between human and guinea pig lung.
    Walsh DA; Salmon M; Featherstone R; Wharton J; Church MK; Polak JM
    Br J Pharmacol; 1994 Dec; 113(4):1407-15. PubMed ID: 7534186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for functional tachykinin NK1 receptors on human isolated small bronchi.
    Naline E; Molimard M; Regoli D; Emonds-Alt X; Bellamy JF; Advenier C
    Am J Physiol; 1996 Nov; 271(5 Pt 1):L763-7. PubMed ID: 8944719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contractile effect of tachykinins on Suncus murinus (house musk shrew) isolated ileum.
    Cheng FH; Chan SW; Rudd JA
    Neuropeptides; 2008; 42(5-6):671-9. PubMed ID: 18582934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.